I expect BAL to release very strong annual results for the 2018 financial year.
Majority revenue is still coming from Australian market.
Recent Vaccine Scandal in China, just does not help Chinese mums buying infant formula in China, would drive them to buy infant formula direct from overseas, imo.
A2 infant formula revenue increase was mainly coming from Australian & New Zealand's markets, as China & other Asia's markets revenue was increased from $114m to $119m.
- Forums
- ASX - By Stock
- BAL
- FY18 Guide & Annual Results
FY18 Guide & Annual Results, page-9
-
- There are more pages in this discussion • 697 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BAL (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
SPONSORED BY The Market Online